Alembic Pharma gets USFDA nod for Tretinoin Cream 0.05%

12 Jun 2026via NSE FilingSource

English हिंदी తెలుగు தமிழ்ಕನ್ನಡ मराठी বাংলা ગુજરાતી

Alembic Pharma gets USFDA nod for Tretinoin Cream 0.05%. Alembic Pharmaceuticals has received final approval from the USFDA for Tretinoin Cream USP, 0.05%, used for topical dermatological treatment. This approval allows the company to market the generic version in the US, expanding its dermatology portfolio. The product is therapeutically equivalent to the reference listed drug.

📊 STOCKS: APLLTB | 🏢 SECTOR: Pharma | #MEDIUMIMPACT #USFDA

#USFDA#approval#AlembicPharma

Stocks mentioned

APLLTDAPLLTD

⚠️ This brief is AI-generated from public news sources for informational purposes only. Not investment advice. Always consult a SEBI-registered advisor before trading.

Trade smarter on NSE

Live option chains, FII flows, PCR, AI analysis — for NIFTY, BANKNIFTY & 200+ F&O stocks.

Start for ₹1 →